Rx (Prescription Medicine)
USD $ 23.00
舒维替尼 50毫克 胶囊是一种靶向癌症疗法，用于治疗晚期肾癌、胃肠道间质瘤 (GIST) 和胰腺神经内分泌肿瘤。应按照医生处方口服。
舒维替尼 50毫克 胶囊是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分舒尼替尼通过抑制对癌细胞生长和增殖至关重要的特定酶（酪氨酸激酶）发挥作用。这种机制有助于减缓或阻止疾病的进展。
舒维替尼适用于治疗晚期肾细胞癌（肾癌）、伊马替尼耐药的胃肠道间质瘤 (GIST) 和晚期胰腺神经内分泌肿瘤 (pNET)。本品以胶囊形式口服给药。
重要注意事项包括告知医生任何既往病史，特别是心脏问题、肝肾问题和甲状腺疾病。舒维替尼可能引起严重的副作用，如疲劳、腹泻、恶心、呕吐和血压变化。治疗期间，医疗专业人员的定期监测至关重要。
将舒维替尼 50毫克 胶囊储存在室温下，避光防潮。请置于儿童无法触及之处。请务必遵循医生的处方和剂量说明。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Sunitinib 50 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
